This effect could be of clinical relevance, since high plasma levels of PAI-1 have been associated with vascular dysfunction and increased cardiovascular risks in several chronic pathological disorders such as hypertension, diabetes and metabolic syndrome (Naya et al., 2007; Lijnen, 2009; Sillen and Declerck, 2020). The gene discussed is SERPINE1; the disease is metabolic syndrome.